Reductions in LVOT Gradients, NYHA Class, & NT-proBNP with Cardiac Myosin Inhibitor in HCM
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
- Heart Matters
Exploring the Use of AI to Detect HFpEF
Patricia A. Pellikka, M.D.
- ACC Action Center
Updates from ACC 2023: Examining Transcatheter Repair Study Data
Paul Sorajja, MD
- ACC Action Center
Cardio-Oncology: Key Clinical Data from ACC.23
Ana Barac, MD, PhD
- ACC Action Center
Highlights from Day 3 of ACC.23